Herbal-Drug Interactions
Herbal supplements are widely used but poorly regulated. St. John's wort, ginkgo, garlic, and many others cause clinically significant drug interactions that patients rarely report.
## The Hidden Risk
Over 25% of adults use herbal supplements, yet fewer than half disclose this to their healthcare providers. Unlike prescription drugs, herbal products are not required to undergo rigorous interaction testing before marketing. Batch-to-batch variability in active compound concentrations adds further unpredictability.
## St. John's Wort (Hypericum perforatum)
The most well-documented herbal interaction offender. St. John's wort potently induces CYP3A4, CYP2C9, CYP1A2, and P-glycoprotein through PXR activation — a profile comparable to rifampin.
**Drugs with dangerous interactions:**
- **Cyclosporine/tacrolimus** — multiple cases of transplant rejection
- **HIV protease inhibitors** — subtherapeutic levels and treatment failure
- **Oral contraceptives** — breakthrough bleeding and unintended pregnancy
- **Warfarin** — reduced INR and increased thrombosis risk
- **SSRIs** — serotonin syndrome risk (St. John's wort is also serotonergic)
- **Digoxin** — reduced levels via P-gp induction
Effects develop over 1-2 weeks and persist for a similar period after discontinuation.
## Ginkgo biloba
Ginkgo inhibits platelet-activating factor (PAF) and has mild CYP-modulating properties:
- **Anticoagulants/antiplatelets** — increased bleeding risk; case reports of intracranial hemorrhage with warfarin
- **NSAIDs** — additive bleeding risk
- **CYP2C19 substrates** — ginkgo may inhibit CYP2C19, increasing levels of omeprazole and diazepam
- **Seizure threshold** — ginkgotoxin (present in seeds, occasionally in leaf extracts) may lower seizure threshold
## Garlic Supplements
Concentrated garlic supplements (not culinary garlic) affect drug metabolism:
- **CYP3A4 substrates** — modest induction; reduced saquinavir levels by 50% in pharmacokinetic studies
- **Anticoagulants** — garlic inhibits platelet aggregation; additive bleeding risk
- **Hypoglycemic agents** — mild additive blood sugar lowering
## Other Clinically Relevant Herbals
| Herbal | Key Interaction | Mechanism |
|--------|----------------|-----------|
| Kava | Hepatotoxicity with hepatotoxic drugs | Additive liver injury; CYP2E1 inhibition |
| Ginseng | Reduced warfarin effect | Possible CYP induction; uncertain mechanism |
| Echinacea | CYP3A4 modulation (variable) | May inhibit or induce depending on preparation |
| Valerian | Additive CNS depression | GABAergic activity |
| Goldenseal | CYP2D6 and CYP3A4 inhibition | Berberine and hydrastine are potent inhibitors |
| Milk thistle | Mild CYP3A4/2C9 inhibition | Silybin is the active component; clinically modest |
## Clinical Recommendations
1. **Always ask about herbal supplements** during medication reconciliation
2. **St. John's wort should be treated as a strong inducer** equivalent to rifampin in interaction assessments
3. **Discontinue herbals** at least 2 weeks before elective surgery (bleeding risk with ginkgo, garlic, ginseng)
4. **Avoid herbals** in transplant patients, those on anticoagulants, and HIV patients on antiretrovirals
5. **Check Natural Medicines database** (naturalmedicines.therapeuticresearch.com) for evidence-graded interactions
## Key Takeaways
- St. John's wort induces CYP3A4 and P-gp as potently as rifampin; transplant rejection and contraceptive failure are documented
- Ginkgo increases bleeding risk with anticoagulants and antiplatelets
- Fewer than half of herbal supplement users tell their doctors
- Goldenseal inhibits CYP2D6 and CYP3A4, potentially raising levels of many drugs
- Discontinue herbals 2 weeks before surgery